Haemophilia is an inherited bleeding disorder in which the blood does not clot properly due to a lack of clotting factors.

A spontaneous hematoma reminds columnist Jennifer Lynne of the importance of taking all symptoms and bleeding seriously with hemophilia.

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 ...

Pfizer’s Hympavzi (marstacimab) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...

Many people in Kenya may be living with an undiagnosed rare bleeding disorder known as hemophilia, which may put them at risk ...

The guidance from NICE recommends the use of Altuvoct in England and Wales as a treatment option for people with severe ...

Genetic mutation causing hemophilia in European monarchies, underdiagnosed in India, requires improved treatment and ...

Hemophilia is a genetic condition where the body doesn't produce enough of the clotting factors needed to stop bleeding. Know ...

This World Hemophilia Day, let us break the silence surrounding bleeding disorders in both women and men and advocate for ...

On the occasion of World Hemophilia Day, let us reflect on this disorder and examine the current state of treatment for ...

The clinic aims to improve access to testing for haemophilia, a genetic condition affecting blood clotting in an estimated 1 ...